Families Fight Trump Administration’s Ban on Medical Care for Trans Youth

A group of families in New Hampshire initiated legal action against the Trump administration to prevent the enforcement of a rule prohibiting federal Medicaid funds for gender-affirming healthcare for minors. The families, alongside GLAD Law, the National Center for LGBTQ Rights and the ACLU of New Hampshire, contend that this rule contravenes existing Medicaid legislation and exceeds the administration’s authority. Scheduled for implementation on October 13, the rule bars Medicaid from financing ‘sex-rejecting procedures for children under 18’ and restricts the Children’s Health Insurance Plan from covering similar treatments for individuals under 19.

Chris Erchull, a senior staff attorney for GLAD, addressed the issue stating, ‘These families made medical decisions with their doctors, based on careful assessment of their children’s individual medical needs. On October 13, the Trump administration wants to pull the funding for their care mid-treatment, with no plan for what happens to them. We’re asking the court to act quickly so these families don’t lose the medical care that has enabled their kids to thrive.’ The legal complaint, filed in the U.S. District Court for the District of New Hampshire, asserts the rule results from a ‘political directive’ rather than ‘reasoned deliberation,’ maintaining funding for pharmaceutical and surgical interventions for non-gender dysphoria diagnoses despite identical treatments.

The lawsuit suggests that unless the court intervenes, transgender adolescents reliant on Medicaid and CHIP will lose access to treatments deemed medically necessary by their physicians—recognized by all major medical associations in the U.S. as safe and effective when prescribed suitably. Beneficiaries receiving cross-sex hormone therapy may continue claiming benefits for six months following the rule’s effective date. The plaintiffs seek the rule’s declaration as unlawful and its prevention from becoming enforceable.

Meanwhile, other significant policy developments are occurring in the healthcare sector. Senator Chuck Grassley (R-Iowa) urged the Trump administration to finalize a rule restricting kratom sales, a plant with opioid-like properties accessible over-the-counter. Moreover, four Republican senators requested the Justice Department investigate Chinese criminal networks allegedly exploiting federal law vulnerabilities within the cannabis and intoxicating hemp markets.

In another legal matter, attorneys general from anti-abortion states challenged abortion shield laws in New York, Massachusetts, and California, asserting these laws contravene four federal regulations. Additionally, the White House began dispatching $500 ‘refund’ checks to about a million Americans overcharged for ObamaCare insurance.

Nationwide headlines spotlight local Medicaid issues, with thousands in Washington facing coverage loss due to federal cuts and legal action in California over health insurance premium hikes. Montana enforces Medicaid work requirements, causing confusion among patients.